Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

41. Purulent acute otitis media in adults

Purulent acute otitis media in adults Memo sheet Purulent acute otitis media in adults November 2016 www.has-sante.fr 5 avenue du Stade de France - 93218 Saint-Denis La Plaine CEDEX Tel.: +33(0)1 55 93 70 00 - Fax: +33(0)1 55 93 74 00 The purpose of this memo sheet is to promote the appropriate prescription of antibiotics to reduce bacterial resistance, which may lead to therapeutic impasses. The choice of antibiotic, its dose and its dosage are factors to consider for a suitable prescription

2016 HAS Guidelines

42. Purulent acute otitis media in children over 3 months

Purulent acute otitis media in children over 3 months Memo Sheet Purulent acute otitis media in children over 3 months November 2016 In case of congestive or seromucinous acute otitis media: no antibiotics. In case of purulent acute otitis media: • children 2 years with mild symptoms: no antibiotics; • children > 2 years with severe symptoms: amoxicillin, 80 or 90 mg/kg/day, for 5 days. If conjunctivitis-otitis syndrome: amoxicillin-clavulanic acid, 80 mg/kg/day, for 8-10 days

2016 HAS Guidelines

43. The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation

The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website

Full Text available with Trip Pro

2015 NIHR HTA programme

44. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care

An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search

2015 NIHR HTA programme

45. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial (PubMed)

Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial Otitis media with effusion is a common problem that lacks an evidence-based nonsurgical treatment option. We assessed the clinical effectiveness of treatment with a nasal balloon device in a primary care setting.We conducted an open, pragmatic randomized controlled trial set in 43 family practices in the United Kingdom. Children aged 4-11 years with a recent (...) history of ear symptoms and otitis media with effusion in 1 or both ears, confirmed by tympanometry, were allocated to receive either autoinflation 3 times daily for 1-3 months plus usual care or usual care alone. Clearance of middle-ear fluid at 1 and 3 months was assessed by experts masked to allocation.Of 320 children enrolled, those receiving autoinflation were more likely than controls to have normal tympanograms at 1 month (47.3% [62/131] v. 35.6% [47/132]; adjusted relative risk [RR] 1.36, 95

Full Text available with Trip Pro

2015 EvidenceUpdates

46. Antibiotics for acute otitis media in children. (PubMed)

Antibiotics for acute otitis media in children. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Antibiotic use for AOM varies from 56% in the Netherlands to 95% in the USA, Canada and Australia. This is an update of a Cochrane review first published in The Cochrane Library in Issue 1, 1997 and previously updated in 1999, 2005, 2009 and 2013.To assess the effects of antibiotics for children with AOM.We searched CENTRAL (2015, Issue 3), MEDLINE (1966 (...) of children with tympanic membrane perforations (RR 0.37, 95% CI 0.18 to 0.76; NNTB 33) and halved contralateral otitis episodes (RR 0.49, 95% CI 0.25 to 0.95; NNTB 11) compared with placebo. However, antibiotics neither reduced the number of children with abnormal tympanometry findings at three months (RR 0.97, 95% CI 0.76 to 1.24) nor the number of children with late AOM recurrences (RR 0.93, 95% CI 0.78 to 1.10) when compared with placebo. Severe complications were rare and did not differ between

Full Text available with Trip Pro

2015 Cochrane

47. Otitis media - acute

Otitis media - acute Otitis media - acute - NICE CKS Clinical Knowledge Summaries Share Otitis media - acute: Summary Acute otitis media (AOM) is defined as the presence of inflammation in the middle ear, associated with an effusion, and accompanied by the rapid onset of symptoms and signs of an ear infection. It is a common condition that can be caused by both viruses and bacteria. AOM occurs frequently in children but is less common in adults. It most commonly affects children from birth to 4 (...) recurrent AOM include: In children — avoiding exposure to passive smoking, use of dummies, and flat, supine feeding; and ensuring that children have had a complete course of pneumococcal vaccinations as part of the routine childhood immunization schedule. In adults — avoiding smoking and/or passive smoking. Have I got the right topic? Have I got the right topic? From age 1 month onwards. This CKS topic is largely based on a National Institute for Health and Care Excellence (NICE) guideline Otitis media

2015 NICE Clinical Knowledge Summaries

48. Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study

Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you

2014 NIHR HTA programme

49. Ciloxan (Ciprofloxacin) - otitis externa or otitis media

Ciloxan (Ciprofloxacin) - otitis externa or otitis media 1/16 The legally binding text is the original French Version TRANSPARENCY COMMITTEE OPINION 19 October 2011 CILOXAN 3 mg/ml, ear drops, solution B/1 bottle of 5 ml (CIP code: 3601303) Applicant: ALCON FRANCE Ciprofloxacin ATC code: S02AA (antibiotic from the fluoroquinolone family) List I Date of Marketing Authorisation: 28 November 2002, amendment of 14 May 2008 Reason for request: Inclusion on the list of medicines refundable (...) by National Health Insurance and approved for hospital use. Medical, Economic and Public Health Assessment Division 2/16 1 CHARACTERISTICS OF THE MEDICINAL PRODUCT 1.1. Active ingredient Ciprofloxacin 1.2. Indication "Antibiotic treatment for adults and children from 1 year: - for acute otitis externa - for purulent otorrhea of the mastoid cavity and chronic suppurative otitis media with tympanic perforation. Consideration should be given to official guidance on the appropriate use of antibacterial agents

2014 Haute Autorite de sante

50. Zinc supplements for preventing otitis media. (PubMed)

Zinc supplements for preventing otitis media. Otitis media is inflammation of the middle ear and is usually caused by infection. It affects people of all ages but is particularly common in young children. Around 164 million people worldwide have long-term hearing loss caused by this condition, 90% of them in low-income countries. As zinc supplements prevent pneumonia in disadvantaged children, we wanted to investigate whether zinc supplements could also prevent otitis media.To evaluate whether (...) zinc supplements prevent otitis media in adults and children of different ages.We searched CENTRAL (2014, Issue 1), MEDLINE (1950 to February week 4, 2014) and EMBASE (1974 to March 2014).Randomised, placebo-controlled trials of zinc supplements given at least once a week for at least a month for preventing otitis media.Two review authors independently assessed the eligibility and methodological quality of the included trials and extracted and analysed data. We summarised results using risk ratios

Full Text available with Trip Pro

2014 Cochrane

51. Pneumococcal conjugate vaccines for preventing otitis media. (PubMed)

Pneumococcal conjugate vaccines for preventing otitis media. Acute otitis media (AOM) is a very common respiratory infection in early infancy and childhood. The marginal benefits of antibiotics for AOM in low-risk populations in general, the increasing problem of bacterial resistance to antibiotics and the huge estimated direct and indirect annual costs associated with otitis media (OM) have prompted a search for effective vaccines to prevent AOM.To assess the effect of pneumococcal conjugate

Full Text available with Trip Pro

2014 Cochrane

52. Xylitol syrup for the prevention of acute otitis media (PubMed)

Xylitol syrup for the prevention of acute otitis media Acute otitis media (AOM) is a common childhood illness and the leading indication for antibiotic prescriptions for US children. Xylitol, a naturally occurring sugar alcohol, can reduce AOM when given 5 times per day as a gum or syrup, but a more convenient dosing regimen is needed for widespread adoption.We designed a pragmatic practice-based randomized controlled trial to determine if viscous xylitol solution at a dose of 5 g 3 times per (...) day could reduce the occurrence of clinically diagnosed AOM among otitis-prone children 6 months through 5 years of age.A total of 326 subjects were enrolled, with 160 allocated to xylitol and 166 to placebo. In the primary analysis of time to first clinically diagnosed AOM episode, the hazard ratio for xylitol versus placebo recipients was 0.88 (95% confidence interval [CI] 0.61 to 1.3). In secondary analyses, the incidence of AOM was 0.53 episodes per 90 days in the xylitol group versus 0.59

Full Text available with Trip Pro

2014 EvidenceUpdates

53. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis.

Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information

2014 NIHR HTA programme

54. Systematic review and meta-analysis: Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media

Systematic review and meta-analysis: Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media Article Text Therapeutics Systematic review and meta

2014 Evidence-Based Medicine (Requires free registration)

55. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis

Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information

2014 NIHR HTA programme

56. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. (PubMed)

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Acute otitis media (AOM) is a common problem in children, for which amoxicillin, with or without clavulanate, is frequently prescribed as a treatment of choice. The conventional recommendation is either three or four daily doses. However, nowadays it is frequently prescribed as once or twice daily doses. If once or twice daily amoxicillin, with or without clavulanate (...) , is as effective for acute otitis media as three or four times a day, it may be more convenient to give the medication once or twice a day to children and hence improve compliance.To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children; and to compare complication rates and adverse reactions.We searched CENTRAL 2013, Issue 2, MEDLINE (January 1950 to March week 1, 2013), EMBASE (1974 to March 2013

Full Text available with Trip Pro

2013 Cochrane

57. Otitis media with effusion: comparative effectiveness of treatments

Otitis media with effusion: comparative effectiveness of treatments Otitis media with effusion: comparative effectiveness of treatments Otitis media with effusion: comparative effectiveness of treatments Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A. Otitis media with effusion: comparative effectiveness of treatments. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 101. 2013 Authors' objectives To compare benefits and harms of strategies currently in use for managing otitis media with effusion (OME). Treatment for OME may include single approaches alone or combinations of two or more approaches. We compared

2013 Health Technology Assessment (HTA) Database.

58. Otitis media - chronic suppurative

Otitis media - chronic suppurative Otitis media - chronic suppurative - NICE CKS Clinical Knowledge Summaries Share Otitis media - chronic suppurative: Summary Chronic suppurative otitis media (CSOM) is defined as 'a chronic inflammation of the middle ear and mastoid cavity, which presents with recurrent ear discharges (otorrhoea) through a tympanic perforation’. CSOM is assumed to be a complication of acute otitis media (AOM). The World Health Organization definition states that AOM (...) topic? Have I got the right topic? From age 1 month onwards. This CKS topic covers the assessment and management of suspected chronic suppurative otitis media (CSOM) in primary care. This CKS topic does not cover advice on treatments used for CSOM in secondary care, such as antibiotics, aural cleansing, or surgery. There are separate CKS topics on , , , and . The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary

2013 NICE Clinical Knowledge Summaries

59. Diagnosis and Management of Acute Otitis Media

Diagnosis and Management of Acute Otitis Media The Diagnosis and Management of Acute Otitis Media | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. The Diagnosis and Management of Acute Otitis (...) Media Allan S. Lieberthal , Aaron E. Carroll , Tasnee Chonmaitree , Theodore G. Ganiats , Alejandro Hoberman , Mary Anne Jackson , Mark D. Joffe , Donald T. Miller , Richard M. Rosenfeld , Xavier D. Sevilla , Richard H. Schwartz , Pauline A. Thomas , David E. Tunkel This article has a correction. Please see: Abstract This evidence-based clinical practice guideline is a revision of the 2004 acute otitis media (AOM) guideline from the American Academy of Pediatrics (AAP) and American Academy of Family

2013 American Academy of Family Physicians

60. The Diagnosis and Management of Acute Otitis Media

The Diagnosis and Management of Acute Otitis Media The Diagnosis and Management of Acute Otitis Media | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. The Diagnosis and Management of Acute Otitis (...) Media Allan S. Lieberthal , Aaron E. Carroll , Tasnee Chonmaitree , Theodore G. Ganiats , Alejandro Hoberman , Mary Anne Jackson , Mark D. Joffe , Donald T. Miller , Richard M. Rosenfeld , Xavier D. Sevilla , Richard H. Schwartz , Pauline A. Thomas , David E. Tunkel This article has a correction. Please see: Abstract This evidence-based clinical practice guideline is a revision of the 2004 acute otitis media (AOM) guideline from the American Academy of Pediatrics (AAP) and American Academy of Family

2013 American Academy of Pediatrics